This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Leendert van den Bos
Chief Executive Officer at EnzyTag BV


Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. He joined Organon BioSciences as a Scientist in 2007 and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development on steroids, carbohydrate, alkaloids and peptide therapeutics. In January 2019 he joined that biotech start-up EnzyTag BV.

Agenda Sessions

  • Chemo-enzymatic Peptide Synthesis; Peptide Chain Length Becomes Less Relevant